← Back to Patent Explorer
US4703045A Expired / Lapsed US ⏱️ 0.0 years remaining

Therapeutic compositions for the treatment of hangover

Assignee: Ipsen Pharma SAS
•
Filing: 1986-03-10
•
Granted: 1987-10-27
•
Expires: 2006-03-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to therapeutic compositions containing betaine salts for the treatment of hangover and for the lowering of alcohol content in blood in human. Daily dose comprises oral administration of 1 to 30 g, associated with appropriate carrier. Optional ingredients are an analgesic, a buffering agent and caffeine.

Inventors

  • 👤 Philippe M. Guinot

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 16:26
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505; A61K31/519; A61K31/52; A61K31/185; A61K31/205; A61K31/60; A61P; A61P9/00; A61P9/06

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 67 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, a hangover symptom relieving amount of a therapeutically acceptable betaine salt and one or more of (a) pain relieving amount of analgesic selected from within the group of acetyl salicyclic acid, a para-aminophenol derivative and ibuprofen, (b) an acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
Claim 2
Dependent Claim 67 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, a hangover symptom relieving amount of a therapeutically acceptable betaine salt and one or more of (a) pain relieving amount of analgesic selected from within the group of acetyl salicyclic acid, a para-aminophenol derivative and ibuprofen, (b) an acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
Claim 3
Dependent Claim 31 words
The medicinal composition of claim 1 wherein said therapeutic composition is in the form of a tablet, capsule, or liquid for oral administration to a human in need of said compound.
Claim 4
Dependent Claim 66 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, a hangover symptom relieving amount of a betaine citrate and one or more of (a) a pain relieving amount of analgesic selected from within the group of acetyl salicylic acid, a para-aminophenol derivative and ibuprofen, (b) an acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
Claim 5
Dependent Claim 66 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, a hangover symptom relieving amount of a betaine citrate and one or more of (a) a pain relieving amount of analgesic selected from within the group of acetyl salicylic acid, a para-aminophenol derivative and ibuprofen, (b) an acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
Claim 6
Dependent Claim 35 words
A method of treating a human in need of relief of hangover symptoms resulting from overindulgence of ethanol, said method comprising administering to said human a therapeutically effective amount of the composition of claim 1.
Claim 7
Dependent Claim 35 words
A method of treating a human in need of relief of hangover symptoms resulting from overindulgence of ethanol, said method comprising administering to said human a therapeutically effective amount of the composition of claim 3.
Claim 8
Dependent Claim 31 words
The medicinal composition of claim 3 wherein said medicinal composition is in the form of a tablet, capsule, or liquid for oral administration to a human in need of said compound.
Claim 9
Dependent Claim 33 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, 1 to 30 grams of a therapeutically acceptable betaine salt and 100 to 325 mg of a para-aminophenol derivative.
Claim 10
Dependent Claim 33 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, 1 to 30 grams of a therapeutically acceptable betaine salt and 100 to 325 mg of a para-aminophenol derivative.
Claim 11
Dependent Claim 12 words
The medicinal composition of claim 7 wherein the para-aminophenol derivative is acetaminophen.
Claim 12
Dependent Claim 51 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, 1 to 24 grams of a therapeutically acceptable betaine salt and (a) 100 to 325 mg of a para-aminophenol derivative, (b) 1 to 4 grams of a buffering agent, and (c) 50 to 250 mg of caffeine.
Claim 13
Dependent Claim 51 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, 1 to 24 grams of a therapeutically acceptable betaine salt and (a) 100 to 325 mg of a para-aminophenol derivative, (b) 1 to 4 grams of a buffering agent, and (c) 50 to 250 mg of caffeine.
Claim 14
Dependent Claim 53 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, 1 to 30 grams of a betaine citrate and one or more of (a) 100 to 325 mg of a para-aminophenol derivative, (b) 1 to 4 grams of a buffering agent, and (c) 50 to 250 mg of caffeine.
Claim 15
Dependent Claim 53 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, 1 to 30 grams of a betaine citrate and one or more of (a) 100 to 325 mg of a para-aminophenol derivative, (b) 1 to 4 grams of a buffering agent, and (c) 50 to 250 mg of caffeine.
Claim 16
Dependent Claim 31 words
The medicinal composition of claim 10 wherein said medicinal composition is in the form of a tablet, capsule, or liquid for oral administration to a human in need of said compound.
Claim 17
Dependent Claim 56 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, a hangover symptom relieving amount of a therapeutically acceptable betaine salt and one or more of (a) a pain relieving amount of a para-aminophenol derivative, (b) and acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
Claim 18
Dependent Claim 56 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, a hangover symptom relieving amount of a therapeutically acceptable betaine salt and one or more of (a) a pain relieving amount of a para-aminophenol derivative, (b) and acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
Claim 19
Dependent Claim 54 words
A medicinal composition for oral administration comprising, an admixture with a therapeutically acceptable carrier, a hangover symptom relieving amount of a betaine citrate and one or more of (a) a pain relieving amount of a para-aminophenol derivative, (b) an acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
Claim 20
Dependent Claim 54 words
A medicinal composition for oral administration comprising, an admixture with a therapeutically acceptable carrier, a hangover symptom relieving amount of a betaine citrate and one or more of (a) a pain relieving amount of a para-aminophenol derivative, (b) an acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
Claim 21
Dependent Claim 12 words
The medicinal composition of claim 13 wherein the para-aminophenol derivative is acetaminophen.
Claim 22
Dependent Claim 80 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, 1 to 30 grams of a therapeutically acceptable betaine salt and one or more of (a) an analgesic selected from within the group of 100 mg to 400 mg of acetyl salicylic acid, 100 to 325 mg of a para-aminophenol derivative, and 100 mg to 200 mg of ibuprofen, (b) 1 to 4 grams of a buffering agent, and (c) 50 to 250 mg of caffeine.
Claim 23
Dependent Claim 80 words
A medicinal composition for oral administration comprising, in admixture with a therapeutically acceptable carrier, 1 to 30 grams of a therapeutically acceptable betaine salt and one or more of (a) an analgesic selected from within the group of 100 mg to 400 mg of acetyl salicylic acid, 100 to 325 mg of a para-aminophenol derivative, and 100 mg to 200 mg of ibuprofen, (b) 1 to 4 grams of a buffering agent, and (c) 50 to 250 mg of caffeine.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-10-26 1991-04-27 1991-10-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-10-26 1995-04-27 1995-10-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-10-26 1999-04-27 1999-10-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag